Prof Matti Aapro (University of Geneva) Prof Joachim Fandrey (Essen University, Germany) Prof Dirk Schrijvers (Middelheim Hospital, Antwerp) and Prof Anders Österborg (Karolinska Institutet, Stockholm) discuss the best way to manage anaemia in cancer patients, at the Anaemia Management Update meeting, 7.11.10, Amsterdam. They also discuss highlights from the meeting and cover topics such as frequency of transfusion, shelf life of blood, erythropoiesis-stimulating agents (ESAs), erythropoietin receptors, government regulation, erythropoietic agents, Darbepoetin alfa, Myelodysplastic syndrome and treating elderly patients.This content has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company)